South and Central America Pulsed Field Ablation Market Outlook (2022-2033)

The Increasing Frequency of Atrial Fibrillation

Across South and Central America, atrial fibrillation (AFib) is emerging as a more commonly encountered cardiac condition, reflecting broader changes in lifestyle and healthcare access. Urbanization has brought shifts in diet and physical activity patterns that correlate with a rise in cardiovascular risk factors. Physicians in large metropolitan centers are seeing more patients with palpitations and irregular heart rhythms during routine check‑ups, which has elevated AFib awareness among both patients and primary care providers.

Public health initiatives and expanding cardiology services have also contributed to higher detection rates. In cities such as Sao Paulo, Buenos Aires, and Bogota, advances in non‑invasive monitoring and greater use of ambulatory ECG technologies have helped clinicians identify AFib earlier in its course. This shift has led to more referrals to specialist electrophysiology centers, where treatment planning includes rhythm‑control strategies beyond traditional drug therapy. Patients are becoming better informed about the risks associated with untreated AFib, such as stroke, leading to more proactive discussions with cardiologists.

As AFib is increasingly recognized as a significant contributor to morbidity, the focus on effective interventional options has grown. Electrophysiologists in the region are exploring alternatives to long‑standing thermal ablation techniques, particularly for patients who are younger or who have experienced limited success with medication. Pulsed field ablation (PFA), with its non‑thermal mechanism and potential for reduced collateral tissue injury, is drawing interest in centers looking to optimize rhythm control outcomes. While adoption is still in earlier stages compared with some other regions, growing clinical experience and patient demand are shaping a clearer role for PFA in addressing the rising frequency of AFib across South and Central America.

Advancing Pulsed Field Ablation Technology

Pulsed field ablation (PFA) technology is advancing steadily in South and Central America as electrophysiology teams look for safer and more efficient ways to treat atrial fibrillation. Early clinical experiences in major cardiac centers are demonstrating non‑thermal electrical pulses can be used to isolate arrhythmogenic tissue with precision. These innovations align well with regional priorities, where clinicians aim to improve procedural safety and reduce hospitalization times in complex healthcare environments.

Recent refinements in PFA systems focus on enhanced catheter maneuverability and real‑time guidance features that help clinicians navigate diverse cardiac anatomies. This has been particularly useful in patients with persistent or atypical AFib presentations, where accurate lesion placement makes a significant difference. Electrophysiologists in the region appreciate the ability to integrate advanced mapping technologies with PFA workflows, enabling better visualization of pulmonary veins and adjacent structures during procedures.

Training and knowledge exchange are also contributing to how PFA is evolving locally. Regional cardiology and electrophysiology societies are incorporating PFA into educational forums, case reviews, and hands‑on workshops. These professional development efforts help local specialists understand not only the technical nuances of PFA devices but also best practices for patient selection and procedural planning. As these technologies mature and clinicians gain experience, pulsed field ablation is increasingly seen as a promising component of modern AFib care in South and Central America one that balances innovation with the practical demands of diverse healthcare settings.

The "South and Central America Pulsed Field Ablation Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• South and Central America Pulsed Field Ablation market size and forecast at regional and country levels for all market segments covered under the scope
• South and Central America Pulsed Field Ablation market trends, as well as drivers, restraints, and opportunities
• South and Central America Pulsed Field Ablation market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the South and Central America Pulsed Field Ablation market
• Detailed company profiles, including SWOT analysis

The geographical scope of the South and Central America pulsed field ablation market report is divided into: Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. Brazil held the largest share in 2025.

The Brazilian country has been taking up a dominant position in the South and Central America pulsed field ablation market due to the relatively more developed healthcare system, presence of an enormous number of patients suffering from cardiac arrhythmias, and usage of progressive medical technologies. PFA is superior to conventional thermal ablation because it destroys only the diseased cells without affecting any other organs and tissues, which is important for Brazil, where new cardiac treatment centers have started developing.

Some Brazilian medical institutions, including cardiology centers and hospitals, are creating conditions that will allow performing PFA operations. Cardiologists will be getting training to perform this complex procedure and using progressive devices for cardiac imaging and mapping. Nevertheless, with the consideration of the expensive nature of the equipment and the lack of electrophysiologists who have been trained on how to use the technique away from big cities, the wider application of the method has become difficult. Considering Brazil's dedication towards the development of healthcare facilities, and the inclusion of minimally invasive techniques in its healthcare systems, together with its emphasis on the improvement of the outcome, it has become the epicenter of PFA in South and Central America.

• The report includes qualitative and quantitative data in the South and Central America Pulsed Field Ablation market across product type, application, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the South and Central America Pulsed Field Ablation market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the South and Central America Pulsed Field Ablation market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the South and Central America Pulsed Field Ablation market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 10 cover South and Central America Pulsed Field Ablation market segments by product type, application, end user, and geography across Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. They cover the market revenue, forecast, and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the South and Central America Pulsed Field Ablation market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The South and Central America pulsed field ablation market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the South and Central America pulsed field ablation market are:

• In September 2025, Kardium Inc. announced that its Globe pulsed field ablation system received FDA premarket approval and 510(k) clearances for its integrated pulsed field mapping and ablation platform, positioning the company to enter the US market and extend its global commercial footprint a development that can accelerate availability of Kardium’s PFA technology in Latin American markets via subsequent distribution agreements.
• In November 2024, Johnson & Johnson MedTech announced that it received U.S. FDA approval for its VARIPULSE pulsed field ablation platform, a PFA system fully integrated with the CARTO 3 electro‑anatomical mapping system, enabling the company to strengthen its global electrophysiology portfolio. This approval supports Johnson & Johnson’s broader commercial expansion strategy into markets including Latin America (e.g., Brazil and Mexico) where advanced AFib treatments are increasingly adopted following regulatory clearances.